本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ligand Pharmaceuticals Inc.

109.39
+0.24000.22%
盤後109.390.00000.00%16:05 EDT
成交量:8.11萬
成交額:891.46萬
市值:21.09億
市盈率:-496.22
高:111.42
開:110.85
低:108.50
收:109.15
資料載入中...
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

重要事件披露

8-K - Current report
2021/01/28

重要事件披露

8-K - Current report
2021/01/27

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/01/27

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/06

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/21

重要事件披露

8-K - Current report
2020/12/16

重要事件披露

8-K - Current report
2020/12/10

重要事件披露

8-K/A [Amend] - Current report
2020/12/03

重要事件披露

8-K - Current report
2020/11/23

重要事件披露

8-K - Current report
2020/11/06

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]